CANbridge Pharmaceuticals
Beijing
About CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $236.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: hkg:1228
- Website: canbridgepharma.com
- Phone: +86 (108) 414-8018
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/canbridge-pharmaceuticals-77858 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.